Literature DB >> 10852137

Etiology of autoimmunity.

N Sarvetnick1.   

Abstract

Autoimmunity reflects the destruction of host tissue by the immune system. In my laboratory we are focused on understanding autoimmunity and the complex regulation of the autoimmune process. We believe that host defense mechanisms, which are normally activated to fight microorganisms, can malfunction and attack self. The role of cytokines and other host-elicited factors are a major focus of our group.

Entities:  

Mesh:

Year:  2000        PMID: 10852137     DOI: 10.1385/IR:21:2-3:357

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  14 in total

1.  Immunotherapy of the nonobese diabetic mouse: treatment with an antibody to T-helper lymphocytes.

Authors:  J A Shizuru; C Taylor-Edwards; B A Banks; A K Gregory; C G Fathman
Journal:  Science       Date:  1988-04-29       Impact factor: 47.728

2.  Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes.

Authors:  M A Atkinson; M A Bowman; L Campbell; B L Darrow; D L Kaufman; N K Maclaren
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

3.  The natural history of lymphocyte subsets infiltrating the pancreas of NOD mice.

Authors:  A Signore; P Pozzilli; E A Gale; D Andreani; P C Beverley
Journal:  Diabetologia       Date:  1989-05       Impact factor: 10.122

4.  Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes.

Authors:  D L Kaufman; M Clare-Salzler; J Tian; T Forsthuber; G S Ting; P Robinson; M A Atkinson; E E Sercarz; A J Tobin; P V Lehmann
Journal:  Nature       Date:  1993-11-04       Impact factor: 49.962

5.  Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus.

Authors:  D L Kaufman; M G Erlander; M Clare-Salzler; M A Atkinson; N K Maclaren; A J Tobin
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

6.  IL-10 impacts autoimmune diabetes via a CD8+ T cell pathway circumventing the requirement for CD4+ T and B lymphocytes.

Authors:  B Balasa; J D Davies; J Lee; A Good; B T Yeung; N Sarvetnick
Journal:  J Immunol       Date:  1998-10-15       Impact factor: 5.422

7.  T helper cell subsets in insulin-dependent diabetes.

Authors:  J D Katz; C Benoist; D Mathis
Journal:  Science       Date:  1995-05-26       Impact factor: 47.728

8.  Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry.

Authors:  M S Horwitz; L M Bradley; J Harbertson; T Krahl; J Lee; N Sarvetnick
Journal:  Nat Med       Date:  1998-07       Impact factor: 53.440

9.  IL-10 is necessary and sufficient for autoimmune diabetes in conjunction with NOD MHC homozygosity.

Authors:  M S Lee; R Mueller; L S Wicker; L B Peterson; N Sarvetnick
Journal:  J Exp Med       Date:  1996-06-01       Impact factor: 14.307

10.  Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles.

Authors:  M Croft; L Carter; S L Swain; R W Dutton
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307

View more
  3 in total

Review 1.  Genetic vaccination for re-establishing T-cell tolerance in type 1 diabetes.

Authors:  Mark C Johnson; Bo Wang; Roland Tisch
Journal:  Hum Vaccin       Date:  2011-01-01

2.  Parameters influencing antigen-specific immunotherapy for Type 1 diabetes.

Authors:  Bo Wang; Roland Tisch
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

3.  Parameters influencing antigen-specific immunotherapy for type 1 diabetes.

Authors:  Bo Wang; Roland Tisch
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.